|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130 EUR | 0.00% |
|
+0.78% | -1.22% |
| Apr. 26 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
| Apr. 26 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
Redcare Pharmacy NV provided sales guidance for the year 2024. For the year, the company expects total sales of $2.3 billion to $2.5 billion, which is a growth of 30% to 40%.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.22% | 2.8B | |
| -31.97% | 10.84B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -30.42% | 6.06B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
REDCARE PHARMACY NV 
